Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
Alternative names
vx-001 (1 trial)
vx-006 (1 trial)
omega-3 fatty acids (Omacor) (1 trial)
soybean oil (Intralipid) (1 trial)
Carcinoma, Non-Small-Cell Lung (Phase 2)
Neoplasms (Phase 1)
Trials (3 total)
Trial APIs (4 total)